Insider buying last 90 days
No open-market insider purchases were filed for GEHC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every GEHC insider filing, plotted on the chart in Gekko.Open GEHC in Gekko
NASDAQ: GEHC
GE HealthCare Technologies (GEHC) Stock Analysis & Forecast
Nov 4 close
$85.81+5.15 (+6.4%)
Gekko Brief
Nov 4 closeGE HealthCare Technologies closed at $85.81 on 4 November 2026, +6.4% on the day. The price sits between the 50-day ($68.91) and 200-day ($69.83) moving averages, inside a 52-week range of $58.75 to $89.77. The GekkoIndex reads 32.3, in the Selling zone, down 7.7 points over five sessions. Gekko Fair Value is $102.40, so the price is 16.2% below it.
The next earnings report is due on 3 February 2027, 90 days away (before open). Over the last 8 reports the company beat the earnings estimate 7 times, with an average move of 6.7% across the report. Smart-money activity over the last 90 days includes 1 Congress purchase and 0 sales. Over the last 30 days there was 1 unusual options signal. Seasonally, the next 20 trading days from this point averaged +1.5% over the last 3 years, rising in 1 of them.
13 firms rate the stock: 8 buy, 5 hold and 0 sell, with a consensus target of $87.50. A typical daily move is about 3.1%, and a typical 20-day move about 5.3%. On the swing-trade checklist, 3 items read supportive and 1 reads as a headwind (gekkoindex).
A plain summary of the figures as of the Nov 4, 2026 close.
GE HealthCare Technologies price vs fair value
Close $85.81200-day averageGekko Fair Value $102.40
GE HealthCare Technologies quick facts
- Market cap
- $38.80B
- P/E ratio
- 16.8
- Forward P/E
- 13.9
- EPS, TTM
- $4.73
- Revenue, TTM
- $21.64B
- Profit margin
- 10%
- Dividend yield
- 0.19%
- Beta
- 0.77
- Volume
- 9.60M avg 4.27M
- 1-year return
- +15.2%
- Typical daily move
- ±3.1%
- Typical 20-day move
- ±5.3%
- 50-day average
- $68.91
- 200-day average
- $69.83
- Next earnings
- Feb 3 before open
- Shares outstanding
- 452.1M
GE HealthCare Technologies swing-trade checklist
GE HealthCare Technologies scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $85.81 sits between the 50-day ($68.91) and 200-day ($69.83) averages, or the averages disagree.
See the chart - GekkoIndexheadwind
32.3, Selling
Reading 32.3 is in the Selling zone.
See the GekkoIndex - Fair valuesupportive
16.2% below
Price is 16.2% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 1 buy / 0 sales. Last 30 days: 1 unusual options signal.
See smart money - Earnings risksupportive
Reports in 90 days
Next report Feb 3, 2027, 90 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+1.5% on average
From this point in the calendar, the next 20 trading days averaged +1.5% over 3 years, rising in 1 of them.
See seasonality
A description of current data, not a recommendation. How this page works
GE HealthCare Technologies stock chart and price history
GE HealthCare Technologies closed at $85.81 on Nov 4, 2026, +15.2% over the past year, inside a 52-week range of $58.75 to $89.77.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +32.5%
- 3 months
- +22.0%
- 6 months
- +39.0%
- 1 year
- +15.2%
The full GEHC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open GEHC in Gekko
Follow GE HealthCare Technologies through every session
Put GEHC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track GEHC in GekkoFree for 7 days. No credit card required.
About GE HealthCare Technologies
GE HealthCare Technologies develops, manufactures and sells medical devices, related services and digital tools used to help diagnose, treat and monitor patients. It is known for its diagnostic imaging equipment, covering molecular imaging, CT, MR, image-guided therapy and X-ray systems, as well as products aimed at women's health. Its customers include healthcare providers across many countries, among them the United States, Canada, several European nations, parts of the Middle East and Africa, China, Taiwan, Mongolia and Hong Kong.
The business is arranged into four segments. Imaging covers advanced scanning technology, while Ultrasound provides devices used in screening, diagnosis and monitoring across areas such as radiology, cardiovascular care, primary care and surgical guidance, including portable units. Patient Care Solutions supplies monitoring equipment, anesthesia and respiratory devices, cardiology tools and maternal-infant care products, alongside related consumables and digital platforms. Pharmaceutical Diagnostics makes contrast agents used before scans like CT and MR, along with radiopharmaceuticals used in PET and SPECT imaging.
GE HealthCare Technologies was established in 2022 and is headquartered in Chicago, Illinois. Its shares are listed on the NASDAQ under the ticker GEHC.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- gehealthcare.com
GE HealthCare Technologies GekkoIndex: the smart money zone
GE HealthCare Technologies’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 32.3, in the Selling zone, down 7.7 points over five sessions.
32.3Selling
Down 7.7 points over five sessions, from the Distribution zone.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 44 | +1.3% | +6.4% | ||
| Accumulation | 249 | +0.3% | +0.3% | ||
| Neutral | 382 | −0.3% | −0.8% | ||
| Distribution | 21 | +2.1% | +2.8% | ||
| Selling (current zone) | 1 | Too few readings yet | |||
Average GEHC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Selling readings averaged +7.3% over 20 days. Past behaviour doesn’t guarantee future results.
Selling zone: Smart money likely exiting positions. About the five zones →
See every daily GekkoIndex reading plotted over the GEHC price, zone by zone.Track GEHC in Gekko
Is GE HealthCare Technologies stock overvalued? Gekko Fair Value
GE HealthCare Technologies trades 16.2% below Gekko Fair Value of $102.40, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what GE HealthCare Technologies shares are worth, recalculated every trading day.
$102.40
Gekko Fair Value, Nov 4, 2026
16.2% Undervalued
At the end of Aug 2026 the price was 34.6% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open GEHC in Gekko
GE HealthCare Technologies insider and Congress trading
No open-market insider purchases were filed for GE HealthCare Technologies, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 11 |
From congressional disclosures, which report amounts as ranges.
Buybacks
GE HealthCare Technologies has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $200.0M
- As a share of market cap
- 0.52%
From company filings.
Unusual options activity last 30 days
1signal, 100% of the flagged premium in calls.
Latest: Bullish flow on Oct 13, $747K in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds GEHC.
1added0opened0trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
GE HealthCare Technologies earnings: next date and track record
GE HealthCare Technologies reports on Feb 3, 2027, before the open (90 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Feb 3, 2027
Expected before the open, 90 days away
- EPS estimate
- $1.55
- Revenue estimate
- $5.92B
7 of 8reports beat the EPS estimate
±6.7%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Oct 28, 2026 AI summary
- What they said
- GEHC delivered strong Q3 2026 results with top-line growth and margin expansion across all segments. Advanced imaging solutions and pharmaceutical diagnostics drove healthy orders and backlog. Key regulatory milestones included CE marking for PhotoNova Spectra photon counting CT and pending FDA clearance for Starguide GX SPECT CT. GEHC announced acquisition of SoFi Bioscience to establish US PET radiopharmaceutical supply footprint and strengthen oncology diagnostics pipeline.
- Guidance
- Management raised full year 2026 guidance based on business momentum, though specific revenue and earnings targets were not detailed in this excerpt. CFO William Grogan was set to provide detailed financial guidance in the remainder of the call.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 28, 2026 | $1.34 est $1.20 | $5.51B est $5.35B | +7.5% |
| Jul 29, 2026 | $1.06 est $1.04 | $5.30B est $5.26B | +9.1% |
| Apr 29, 2026 | $0.99 est $1.05 | $5.13B est $5.04B | −11.2% |
| Feb 4, 2026 | $1.44 est $1.40 | $5.70B est $5.61B | +4.5% |
| Oct 29, 2025 | $1.07 est $1.05 | $5.14B est $5.09B | −5.5% |
| Jul 30, 2025 | $1.06 est $0.92 | $5.01B est $4.97B | −8.2% |
| Apr 30, 2025 | $1.01 est $0.91 | $4.78B est $4.66B | −0.6% |
| Feb 13, 2025 | $1.45 est $1.26 | $5.32B est $5.33B | +7.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
GE HealthCare Technologies stock forecast and analyst price targets
Analysts’ average 12-month price target for GE HealthCare Technologies is $87.50, +2.0% from the last close, from 13 firms rating the stock in the last 90 days.
$87.50consensus 12-month target, +2.0% from the last close
Now $85.81Avg $87.50
Low $75High $95
Each firm’s latest rating in the last 90 days: 13 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 3 | UBS | $80 | −6.8% |
| Oct 29 | Oppenheimer | $85 | −0.9% |
| Oct 29 | J.P. Morgan | $80 | −6.8% |
| Oct 29 | BMO Capital | $75 | −12.6% |
| Oct 29 | Mizuho Securities | $90 | +4.9% |
+1.5%average move over the next 20 trading days in the last 3 years
±3.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
GE HealthCare Technologies seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, GE HealthCare Technologies averaged +1.5% across the last 3 years, rising in 1 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.0% | 0 of 3 |
| Next 10 trading days | −2.4% | 1 of 3 |
| Next 15 trading days | +0.7% | 1 of 3 |
| Next 20 trading days | +1.5% | 1 of 3 |
| Next 30 trading days | +2.3% | 2 of 3 |
For scale, GEHC’s typical 20-trading-day move in either direction is about 5.3%.
GE HealthCare Technologies market cap and key statistics
GE HealthCare Technologies’s market cap is $38.80B, with a P/E ratio of 16.8 and revenue of $21.64B over the last twelve months.
Valuation
- Market cap
- $38.80B
- P/E ratio
- 16.8
- Forward P/E
- 13.9
- EPS, TTM
- $4.73
- Gekko Fair Value
- $102.40
Trading
- Volume
- 9.60M
- Avg volume, 20 days
- 4.27M
- 52-week high
- $89.77
- 52-week low
- $58.75
- Shares outstanding
- 452.1M
Financials
- Revenue, TTM
- $21.64B
- Profit margin
- 10%
- Return on equity
- 20%
- Quarterly earnings growth, YoY
- +39.0%
Risk and income
- Beta
- 0.77
- Typical daily move
- ±3.1%
- Typical 20-day move
- ±5.3%
- Dividend yield
- 0.19%
GE HealthCare Technologies stock news this week
Coverage of GE HealthCare Technologies this week reads positive: 16 positive, 4 neutral and 1 negative headlines.
- A former officer proposes selling 78,348 GE HealthCare (GEHC) shares.Stock Titan, Nov 4
- Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath LabMorningstar, Nov 4
- Tampa General Hospital Expands Advanced Image-Guided Care in Clinical Hybrid Operating Room Setting With GE HealthCare Allia MoveoYahoo Finance Singapore, Nov 4
- GE HealthCare Adds 2 AI Tools to Vscan Air Handheld UltrasoundMedical Product Outsourcing, Nov 4
- GEHC Q3 Earnings Call Highlights Raised Outlook and Margin RisksZacks Investment Research, Nov 4
- 5 Green Days In A Row: GE HealthCare Technologies Stock Is Up 13%Trefis, Nov 4
GE HealthCare Technologies peers
GE HealthCare Technologies’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 14.5% above |
| ABTAbbott Laboratories | Distribution | 8.0% below |
| ISRGIntuitive Surgical | Distribution | 30.4% above |
| DHRDanaher | Neutral | 3.6% above |
| MDTMedtronic | Neutral | 16.0% below |
| SYKStryker | Distribution | 6.5% above |
A peer links to its own page where one exists.
GE HealthCare Technologies stock FAQ
What is GE HealthCare Technologies’s market cap?
GE HealthCare Technologies’s market cap is $38.80B at the Nov 4, 2026 close of $85.81, with 452.1M shares outstanding. The shares trade on a P/E ratio of 16.8.
What is the GE HealthCare Technologies stock forecast?
The consensus analyst 12-month price target for GE HealthCare Technologies is $87.50, +2.0% from the last close. Of the 13 firms that rated the stock in the last 90 days, 8 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is GE HealthCare Technologies stock overvalued or undervalued?
On Gekko’s estimate GE HealthCare Technologies is undervalued: the Nov 4, 2026 close of $85.81 is 16.2% below Gekko Fair Value of $102.40. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does GE HealthCare Technologies report earnings next?
GE HealthCare Technologies is expected to report on Feb 3, 2027, before the market opens (90 days away). Analysts expect earnings of $1.55 per share on revenue of $5.92B. GE HealthCare Technologies beat the earnings estimate in 7 of its last 8 reports, moving 6.7% on average across the report.
What is GE HealthCare Technologies’s 52-week high and low?
GE HealthCare Technologies’s 52-week high is $89.77 and its 52-week low is $58.75; it closed at $85.81 on Nov 4, 2026, +15.2% over the past year. Over the last five years the shares peaked at $94.80 on Feb 13, 2025.
Is GE HealthCare Technologies stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (fair value, smart money and earnings risk), 2 as mixed (trend and seasonality) and 1 as a headwind (gekkoindex). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in GE HealthCare Technologies?
Gekko flagged 1 unusual options signal in GE HealthCare Technologies over the last 30 days, with $747K of flagged premium in calls and $0 in puts. The latest, bullish flow, was on Oct 13, 2026 with $747K in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See GE HealthCare Technologies the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.